{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001039423.1:c.6056A>G",
          "cDNA Change": {
            "transcript": "NM_001039423.1",
            "ref": "A",
            "alt": "G",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S (p.G2019S)"
        }
      ]
    },
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000341.2:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_000341.2",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T (p.A53T)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005263"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The experiment was conducted using HEK293 cells expressing LRRK2 G2019S or SNCA A53T variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001039423.1:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "LRRK2 G2019S showed 2.5-fold increased kinase activity compared to wild-type."
        },
        {
          "Variant": "NM_000341.2:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "SNCA A53T exhibited 1.8-fold increased α-synuclein aggregation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 and SNCA plasmids were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 1.5-fold of wild-type; α-synuclein aggregation < 20%.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity > 2-fold of wild-type; α-synuclein aggregation ≥ 30%.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Postmortem brain tissue from Parkinson's disease patients",
        "Description": "Immunohistochemistry was performed on brain tissue samples from Parkinson's disease patients with LRRK2 G2019S or SNCA A53T mutations."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001039423.1:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "LRRK2 G2019S showed increased phosphorylation of α-synuclein in dopaminergic neurons."
        },
        {
          "Variant": "NM_000341.2:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "SNCA A53T exhibited extensive Lewy body pathology in the substantia nigra."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five tissue samples were analyzed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type brain tissue was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-diseased brain tissue was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Chi-square test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal Lewy body pathology; absence of α-synuclein phosphorylation.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Presence of Lewy bodies; α-synuclein phosphorylation ≥ 40%.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}